Predictive factors and impact of no reflow after primary percutaneous coronary intervention in patients with acute myocardial infarction
- PMID: 20118156
- DOI: 10.1161/CIRCINTERVENTIONS.109.896225
Predictive factors and impact of no reflow after primary percutaneous coronary intervention in patients with acute myocardial infarction
Abstract
Background: The investigation of no-reflow phenomenon after percutaneous coronary intervention (PCI) in patients with acute ST-segment-elevation myocardial infarction has therapeutic implications. We investigated the predictive factors, persistence in time, and impact of no reflow on myocardial salvage, ventricular function, and mortality.
Methods and results: The study included 1140 patients with ST-segment-elevation myocardial infarction undergoing primary PCI and paired scintigraphic examinations (before intervention and 7 to 14 days thereafter). After primary PCI, 108 patients had no reflow and 1032 patients had normal coronary flow. The median salvage index was 0.34 (interquartile range, 0.15, 0.49) in patients with no reflow versus 0.55 (interquartile range, 0.29, 0.81) in patients with normal flow (P<0.001). Left ventricular ejection fraction at 6 months after PCI was 47.7+/-13.1% in the no-reflow group versus 54.2+/-13.9% in the group with normal flow after PCI (P<0.001). In 80.3% of patients with no reflow, normalization of blood flow >6 months after PCI occurred and correlated with improvement in the left ventricular ejection fraction. Independent predictors of no reflow were residual flow in the infarct-related artery (P<0.001), initial perfusion defect (P=0.03), C-reactive protein (P<0.001), and previous myocardial infarction (P=0.013). Kaplan-Meier estimates of 1-year mortality were 16.7% (n=18) in patients with no reflow versus 5.5% (n=56) in patients with normal flow (hazard ratio, 3.35; 95% CI, 1.97 to 5.69; P<0.001).
Conclusions: No reflow after primary PCI was associated with reduced myocardial salvage, larger infarct size, worse left ventricular ejection fraction at 6 months, and increased risk of 1-year mortality. In 4 of 5 patients with no reflow after PCI, restoration of normal flow occurred 6 months after reperfusion.
Similar articles
-
Endothelin-1 release in acute myocardial infarction as a predictor of long-term prognosis and no-reflow assessed by contrast-enhanced magnetic resonance imaging.Am Heart J. 2010 May;159(5):882-90. doi: 10.1016/j.ahj.2010.02.019. Am Heart J. 2010. PMID: 20435200
-
[Effect of urapidil on heart function and ventricular systolic synchrony in acute myocardial infarction patients with no-reflow phenomenon after percutaneous coronary intervention].Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2008 Apr;20(4):197-9. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2008. PMID: 18419949 Clinical Trial. Chinese.
-
Prognostic impact of contrast-enhanced CMR early after acute ST segment elevation myocardial infarction (STEMI) in a regional STEMI network: results of the "Herzinfarktverbund Essen".Herz. 2008 Mar;33(2):136-42. doi: 10.1007/s00059-008-3102-8. Herz. 2008. PMID: 18344033
-
New strategies for the management of no-reflow after primary percutaneous coronary intervention.Expert Rev Cardiovasc Ther. 2011 May;9(5):615-30. doi: 10.1586/erc.11.49. Expert Rev Cardiovasc Ther. 2011. PMID: 21615325 Review.
-
No-reflow phenomenon: maintaining vascular integrity.J Cardiovasc Pharmacol Ther. 2011 Sep-Dec;16(3-4):244-50. doi: 10.1177/1074248411405990. J Cardiovasc Pharmacol Ther. 2011. PMID: 21821523 Review.
Cited by
-
Multivessel Coronary Artery Disease and Subsequent Thrombolysis in Myocardial Infarction Flow Grade After Primary Percutaneous Coronary Intervention.Cureus. 2020 Jun 21;12(6):e8752. doi: 10.7759/cureus.8752. Cureus. 2020. PMID: 32714690 Free PMC article.
-
Establishment and validation of a prediction model for nonrecovery of left ventricular ejection fraction in acute myocardial infarction patients combined with decreased left ventricular ejection fraction.Clin Cardiol. 2024 Feb;47(2):e24212. doi: 10.1002/clc.24212. Clin Cardiol. 2024. PMID: 38402553 Free PMC article.
-
Effect of Intravenous Abciximab on Coronary Flow Improvement After Re-vascularization in Primary Coronary Intervention and Short Term Impact.Med Arch. 2020 Aug;74(4):265-269. doi: 10.5455/medarh.2020.74.265-269. Med Arch. 2020. PMID: 33041442 Free PMC article.
-
Association between Neutrophil-to-Lymphocyte Ratio and the Systemic Inflammatory Immunologic Index and the Angiographic SYNTAX Score and the TIMI Flow Grade in Acute STEMI: A Cohort Study.J Tehran Heart Cent. 2021 Oct;16(4):147-155. doi: 10.18502/jthc.v16i4.8600. J Tehran Heart Cent. 2021. PMID: 35935551 Free PMC article.
-
A pilot study of perfusion balloon predilatation in conjunction with intracoronary nicorandil administration for acute coronary syndrome.Cardiovasc Interv Ther. 2025 Jan;40(1):45-56. doi: 10.1007/s12928-024-01034-0. Epub 2024 Aug 13. Cardiovasc Interv Ther. 2025. PMID: 39136888
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous